1 completed, 1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Adenocarcinoma of Kidney: new trials by email Literature Review of Adenocarcinoma of Kidney trials Research Report on Adenocarcinoma of Kidney
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension - Renal Cell Carcinoma, Kidney Cancer | Phase 1 | Withdrawn | NanOlogy, LLC | 2020-04-01 | 2020-08-04 | |
| Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer Renal Cell Carcinoma, Renal Cell Cancer | Completed | Bristol-Myers Squibb | 623 | 2018-01-21 | 2026-06-16 |
Carcinoma, Renal Cell (2) · Kidney Neoplasms (2)
Adenocarcinoma (2) · Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2)
Docetaxel (1) · Powders (1) · Suspensions (1)
Bristol-Myers Squibb (1) · NanOlogy, LLC (1)
France (1)
Rose Marie Cavanna-Mast, RT, CCRA (1)